Introduction
We are a privately held clinical-stage biotechnology company focusing on the development and commercialization of a revolutionary new immune thera...
By Dermavir We are a Phase II therapeutic vaccine company with a lead product candidate for the treatment of HIV.
Although the HIV epidemic, as we know it toda...
By Paschal Keogh
Genetic Immunity
Those of you who regularly investigate upcoming ICOs will be well used to lofty claims. “The world of gambling/investment/social media/dating/pin cushion manufacture will never be the same again!”
Well, her...